After a very soft finish to 2016, the larger publicly traded direct sellers mostly got off to a good start in 2017.
My equity research firm focuses on companies that employ the direct selling business model.
The largest publicly traded direct selling companies continue to post mostly solid financial results despite unrest in some world markets and the ongoing impact of foreign exchange rates.
Herbalife’s settlement with the Federal Trade Commission may have positively impacted its third quarter earnings.
The midyear economic outlook for 2016 is mixed for the largest publicly traded direct selling companies in the U.S., with some posting better-than-expected second quarter results while others saw decline.
The economic outlook for 2016 remains strong among the largest publicly traded direct selling companies, despite some declines.
Fluctuating foreign exchange rates, a strengthening U.S. dollar and economic and political headwinds in global markets combined for disappointing fourth quarter and 2015 year-end results for six leading direct selling giants.
CVSL, USANA, Herbalife, Avon, Nu Skin, Primerica, Nature's Sunshine, Medifast, EDC’s Home Division,
Medifast, Youngevity, ForeverGreen, LifeVantage Corp., Immunotec Inc.,
NuSkin Enterprises Inc., Primerica Inc., Nature’s Sunshine Products Inc., Medifast Inc., Mannatech Inc., Crius Energy Trust, Youngevity International Inc.